Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Lemieux

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Clinical Pharmacology and Therapeutics|March 5, 2010
Obesity, inflammation, and cardiovascular riskP Mathieu, I Lemieux, J-P Després
International Journal of Obesity (2005)|March 30, 2006
Contribution of CB1 blockade to the management of high-risk abdominal obesityJ-P Després, I Lemieux, N Alméras
Diabetes & Metabolism|September 28, 1999
The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspectsB Lamarche, I Lemieux, J P Després
BMJ (Clinical Research Ed.)|March 27, 2001
Treatment of obesity: need to focus on high risk abdominally obese patientsJ P Després, I Lemieux, D Prud'homme
Annales D'Endocrinologie|January 10, 2001
[Risk factors associated with obesity: a metabolic perspective]J P Després, A Pascot, I Lemieux
Journal of Internal Medicine|May 25, 2002
Effects of micronized fenofibrate versus atorvastatin in the treatment of dyslipidaemic patients with low plasma HDL-cholesterol levels: a 12-week randomized trialJ-P Després, I Lemieux, H Salomon, et al.
American Journal of Physiology. Cell Physiology|October 22, 2002
PGE2 reduces arachidonic acid release in murine podocytes: evidence for an autocrine feedback loopLyne I Lemieux, Sherine S Rahal, Chris R J Kennedy
Atherosclerosis|February 13, 2001
HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular studyJ P Després, I Lemieux, G R Dagenais, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 5, 2002
Evaluation and management of atherogenic dyslipidemia: beyond low-density lipoprotein cholesterolJ P Després, I Lemieux, G R Dagenais, et al.
Diabetes & Metabolism|July 14, 2001
[Fat distribution and metabolism]J P Després, I Lemieux, A Tchernof, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Clinical Pharmacology and Therapeutics|March 5, 2010
Obesity, inflammation, and cardiovascular riskP Mathieu, I Lemieux, J-P Després
International Journal of Obesity (2005)|March 30, 2006
Contribution of CB1 blockade to the management of high-risk abdominal obesityJ-P Després, I Lemieux, N Alméras
Diabetes & Metabolism|September 28, 1999
The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspectsB Lamarche, I Lemieux, J P Després
BMJ (Clinical Research Ed.)|March 27, 2001
Treatment of obesity: need to focus on high risk abdominally obese patientsJ P Després, I Lemieux, D Prud'homme
Annales D'Endocrinologie|January 10, 2001
[Risk factors associated with obesity: a metabolic perspective]J P Després, A Pascot, I Lemieux
Journal of Internal Medicine|May 25, 2002
Effects of micronized fenofibrate versus atorvastatin in the treatment of dyslipidaemic patients with low plasma HDL-cholesterol levels: a 12-week randomized trialJ-P Després, I Lemieux, H Salomon, et al.
American Journal of Physiology. Cell Physiology|October 22, 2002
PGE2 reduces arachidonic acid release in murine podocytes: evidence for an autocrine feedback loopLyne I Lemieux, Sherine S Rahal, Chris R J Kennedy
Atherosclerosis|February 13, 2001
HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular studyJ P Després, I Lemieux, G R Dagenais, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 5, 2002
Evaluation and management of atherogenic dyslipidemia: beyond low-density lipoprotein cholesterolJ P Després, I Lemieux, G R Dagenais, et al.
Diabetes & Metabolism|July 14, 2001
[Fat distribution and metabolism]J P Després, I Lemieux, A Tchernof, et al.
Pageof 4